Member Info for Traa-dy-Liooar

for a bit of xmas cheer.

Yes it is looking strong atm. Long may it continue.

Agreed. PI's sick of the company's nonsense, Fowler will have to try a lot harder than that RNS.

Strange old stock. Lots of willing sellers at any movement, even at lows, suggests some legacy sellers and traders.

PI's think - SP didn't move as much as i expected and give me a quick buck . So what i do now - sell? Lol
The expectation and need for immediate reward feeds the mm. Notification of holdings will arrive. This may revisit the 30's , but I for one will be buying. Research and understand of what you are investing in isessential.

Shaping up to be an extensive field.

Could be very material in the post covid world.

spurt in SP and more interestingly, volume. Update due?

from the company would be most welcome at the moment.

Yep looks a good appointment. Seems the new bod is now in place. Also see three of them are now in Glycotest. More patience here but they clearly are putting the building blocks in place, see how it unfolds in coming months.

Appointment of John Clarkson as Executive Chairman of NetScientific (from his previous position as Non-Executive Chairman), as Chairman of NetScientific subsidiary ProAxsis, and as a Director of Glycotest.

How about an update on Glycotest?

perhaps 7am would have done it more justice. Nice tech and green credentials
http://www.sagetechmedical.com/the-problem/

more posts than trades today, sums up the doldrums that nsci is in.

Have a few bob invested here, and would put more in if, and it is a big if, the BoD were somewhat more proactive and aligned with their investors. Glycotest was my main interest, but the lack of an update is worrying. Time for the BoD to deliver some news and interest.

will wait for the eager £5005 seller to finish (£45k thus far today)

Yep, on paper some good investments. lack of regular newsflow kills sentiment, that said, if Glycotest is positive (and it is very overdue) then this moves expeditiously.

is clear. Lack of news will see lower drag, until a point is found that is totally unrealistic. This share moves quick in either direction. What's the NAV of the 15 companies, anyone hazard a guess? certainly more than current m/c . That said, we are in the hands of the BoD, and I suspect VC's are quite sanguine as to timeframes.

Not good reading in the BMJ. Silence from company is not good. Will go lower.

of 10k been about for a while and is somewhat indiscriminate in their approach - sells all the way down to 50. Once they are done, and they must be close, then it should free up somewhat.

Nice to see this moving back up. Long, long way to go and potential for various items of news flow from the portfolio companies. Glycotest update must be close now.